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Summary
APOBEC3 proteins constitute a family of cytidine
deaminases that provide intracellular resistance to ret-
rovirus replication and transposition of endogenous
retroelements [1]. One family member, APOBEC3A
(hA3A), is an orphan, without any known antiviral ac-
tivity. We show that hA3A is catalytically active and
that it, but none of the other family members, potently
inhibits replication of the parvovirus adeno-associ-
ated virus (AAV). hA3A was also a potent inhibitor of
the endogenous LTR retroelements, MusD, IAP, and
the non-LTR retroelement, LINE-1. Its function was de-
pendent on the conserved amino acids of the hA3A ac-
tive site, consistent with a role for cytidine deamina-
tion, although mutations in retroelement sequences
were not found. These findings demonstrate the po-
tent activity of hA3A, an APOBEC3 family member
with no previously identified function. They also high-
light the functional differences between APOBEC3
proteins. The APOBEC3 family members have distinct
functions and may have evolved to resist various clas-
ses of genetic elements.
Results and Discussion
In the human, the APOBEC family consists of APOBEC1
(hA1), APOBEC2 (hA2), and APOBEC3A, B, C, D/E, F, G,
and H (hA3A-H) [2, 3], while the mouse genome encodes
APOBEC1 (mA1), APOBEC2 (mA2), and a single APO-
BEC3 (mA3). HIV-1 has evolved the accessory protein
Vif to block the inhibitory effects of hA3F and hA3G [1,
4]. Virions produced by cells infected with Dvif HIV-1
package hA3G that catalyzes C/U deamination of the
minus-strand reverse transcripts synthesized in the
next round of infection [5–8]. Vif protects the virus by in-
ducing ubiquitination and proteasomal degradation of
hA3G [9–11]. Endogenous LTR retroelements such as
the mouse intracisternal A particle (IAP) and MusD and
human HERV and the non-LTR retroelements such as
LINE-1 comprise a large portion of the mammalian
genome (>42% in the human) and predate lentiviruses
[12, 13]. The elements reverse transcribe their RNA
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to retroviral replication although only a few are active
and capable of retrotransposition [14, 15]. Retrotrans-
position of IAP and MusD (but not LINE-1) is blocked
by hA3G [16, 17], and this is associated with G/A
mutations.
Parvoviruses (family Parvoviridae) are small eukary-
otic DNA viruses that infect humans and a variety of
other animal species [18]. The Parvovirus genome con-
sists of a linear single-stranded DNA (ssDNA) molecule
containing ORFs encoding replication (Rep) and capsid
(Cap) proteins, flanked by hairpins. Parvoviruses are
prevalent in the human population, where they exist as
an array of serotypes of high-sequence diversity [19,
20]. Adeno-associated virus (AAV) requires a helper vi-
rus and replicates in the nucleus through a single-
stranded intermediate.
To test for antiretroviral activity of hA3A, wild-type and
Dvif HIV-1 and SIV luciferase reporter viruses were pre-
pared in transfected 293T cells in the presence or ab-
sence of APOBEC3 expression vectors, and their infec-
tivity was determined on target cells by measurement of
intracellular luciferase. Immunoblot analysis of the vi-
rions confirmed that hA3A was efficiently packaged
into virions, yet in spite of its presence in the virion,
hA3A had no effect on infectivity (Figures 1A and 1D).
In contrast, hA3G potently inhibited Dvif HIV-1 and
SIVagm (Figure 1A and [21]).
hA3A Is a Single-Strand-Specific DNA
Cytidine Deaminase
hA3A contains a single copy of the cytidine deaminase
active site sequence motif HXEX28PCX4C in which the
histidine and two cysteines coordinate a Zn2+ and the
glutamate serves as a proton shuttle in catalysis [2]. To
test for hA3A cytidine deaminase activity, hA3A was
packaged into HIV-1 virions and cytidine deaminase ac-
tivity released from the virions upon detergent lysis was
measured in vitro by incubation with a radiolabeled
deoxyoligonucleotide that contained a single target
cytosine [22]. The substrate preference of hA3A was de-
termined on single-stranded, double-stranded DNA
(DNA:DNA) or double-stranded hybrids (DNA:RNA) sub-
strates. After incubation with virus lysate, the oligonu-
cleotide was cleaved with uracil DNA glycosylase and
treated at high pH, and the products were detected by
autoradiography. hA3A was found to deaminate sin-
gle-stranded DNA but not double-stranded DNA or
DNA:RNA hybrids (Figure 1B). A small amount of the
DNA:RNA hybrid appeared to be deaminated, probably
as a result of a small amount of single-stranded probe
in the preparation. Control virions prepared without
APOBEC3 lacked deaminase activity.
To determine the role of the active site amino acids in
catalysis, hA3A with a point mutation in the Zn2+ coordi-
nation residues H70R or C106S or the catalytic glutamic
acid E72Q were tested for cytidine deaminase activity.
The mutated hA3A molecules were packaged into
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481Figure 1. hA3A Is a Single Strand-Specific DNA Cytidine Deaminase
(A) hA3A does not inhibit HIV-1 or SIVagm.Dvif HIV-1 and SIVagm luciferase reporter virus [5, 29] was produced in 293T cells cotransfected with or
without hA3A or hA3G expression vector, and infectivity of the viruses (1 ng p24/27) was measured by luciferase activity in infected target cells
(left and right). hA3A encapsidated in SIVagm virions and normalized for p27 was detected on an immunoblot probed with anti-HA and anti-CA
mAb. Experiments were performed in triplicate and data are presented as the mean, with error bars reflecting the standard deviation.
(B) HIV-1 virions loaded with or without hA3A or hA3G were incubated in 0.1% Triton-X100 buffer. Cytidine deaminase activity released was mea-
sured by incubation with a 50-32P-labeled deoxyoligonucleotide substrate (CCT40; Figure S1) containing a target C. The deaminated molecules
were cleaved by treatment with uracil DNA glycosylase followed by high pH, and the products were resolved by PAGE and visualized by auto-
radiography. The probe was single-stranded DNA (D), or hybridized to an unlabeled complementary DNA (D/D) or RNA (D/R) at the ratios indi-
cated above. The substrate and deaminated product are indicated.
(C) Catalytic activity of hA3A active site mutants H70R, E72Q, and C106S was measured in the cytidine deaminase assay. Virions loaded with
each mutant were prepared and cytidine deaminase activity was measured as in (B). Virions prepared without hA3A or without viral DNA
were measured as controls.
(D) The HIV-1 virions contained similar amounts of hA3A active site mutant protein. Virion contents were measured on an immunoblot probed
with anti-HA and anti-CA mAbs.
(E) The target sequence preference of the hA3A was determined on a panel of 50-32P-labeled deoxyoligonucleotide substrates, each containing
four target sites. The –1 base is shown at the top of each lane and the +1 base is shown on the left. The structure of the cleaved products is shown
on the right. The control (last lane) is an oligonucleotide with the same sequence at each target site to show the independence of target site po-
sition on cleavage frequency.Dvif HIV-1 virions, and the cytidine deaminase activity
released from the virions was measured. The results
showed that the mutant hA3A proteins were inactive
(Figure 1C). Immunoblot analysis confirmed that they
were packaged at comparable levels (Figure 1D). To
test the site sequence preference of hA3A, a panel of
four oligonucleotides was designed that tests each of
the 16 possible NCN trinucleotide sequence combina-
tions (Figure 1E). The method was validated with hA3G,
which was found to preferentially target the sequence
CCA, consistent with its known specificity [7, 8, 22].This method showed that hA3A prefers the sequence
(T/C)CA.
hA3A Inhibits AAV
Since AAV replicates as single-stranded DNA in the nu-
clei of infected cells, we considered it as a potential
APOBEC3 target. The effect of APOBEC3 proteins on
parvovirus replication was determined by production
of recombinant AAV (rAAV) in a transfection assay (Fig-
ure 2A). Plasmids required for rAAV replication and
packaging were cotransfected into 293 cells together
Current Biology
482Figure 2. hA3A Inhibits AAV Replication
(A) Production of rAAV was inhibited by hA3A but was unaffected by other APOBEC proteins. 293 cells were transfected with plasmids required
for rAAV.GFP production in the presence or absence of APOBEC3 expression vectors. Production of rAAV was assessed by transduction of tar-
get cells and quantitation by FACS. The data in (A) and (D) are the average of triplicate transfections normalized to vector only control. The panels
below show immunoblots to detect HA-tagged hA3A, hA3B, hA3C, hA3G, and His-tagged hA3F. V, vector alone. Experiments were performed in
triplicate and data are presented as the mean, with error bars reflecting the standard deviation.
(B) Southern blot detection of low molecular weight DNA extracted from cells transfected for rAAV production in the presence of increasing
amounts (0, 0.001, 0.01, 0.1, 1.0 mg) of hA3A expression vector. The DNA was digested with Dpn I, separated by gel electrophoresis, and hybrid-
ized with a radiolabeled AAV probe. The arrows indicate AAV replication products. Shown below is an immunoblot to detect HA-tagged hA3A.
(C) Immunofluorescence to detect HA-tagged APOBEC and AAV (Rep) proteins in cells transfected with wild-type and mutant APOBEC and then
infected with AAV and adenovirus. Rep from the input virus is undetectable in this assay, so positive Rep staining is indicative of AAV replication.
Nuclei are stained with DAPI as indicated in the merged panels to the right.
(D) Production of rAAV in 293 cells is inhibited by wild-type but not mutant HA-tagged hA3A in stable cell lines. An immunoblot to detect
HA-tagged hA3A is shown below. Experiments were performed in triplicate and data are presented as the mean, with error bars reflecting
the standard deviation.with APOBEC3 expression vectors. In this system, Rep
and Cap are supplied in trans to enable replication of
an AAV vector and packaging of the ssDNA genome.
rAAV produced is quantitated by transduction of target
cells with cell lysate. hA3A protein was found to com-
pletely block rAAV production. In contrast, hA3B,
hA3C, hA3F, and hA3G had no effect. hA3A did not inter-
fere with the production of helper proteins (see Fig-
ure S2A in the Supplemental Data available with this ar-
ticle online).
Analysis of the low molecular weight DNA extracted
from the transfected cells revealed dramatic inhibition
of rAAV replication by hA3A (Figure 2B). As little as10 ng of plasmid hA3A inhibited replication and particle
production (Figure S2B). None of the APOBEC3 proteins
affected adenovirus or herpes simplex virus replication,
suggesting a requirement for ssDNA (data not shown).
hA3A Is in the Nucleus and Blocks Formation of AAV
Replication Centers
Replication of AAV by helper virus results in the forma-
tion of nuclear viral replication centers that can be de-
tected with antibody to Rep [23, 24]. To visualize the
effect of APOBEC3 proteins on AAV replication, cells
were transfected with hA3G, hA3A, or hA3A C106S and
then infected with wild-type AAV and adenovirus
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(A) The diagram shows the structure of the MusD and IAP neor-marked elements [25]. The reverse orientation neor gene is interrupted by an in-
tron. Expression of functional neor requires splicing of the RNA transcript followed by reverse transcription. Retrotransposition events are scored
as the number of G418-resistant colonies. Arrows indicate transcription initiation sites. SD, splice donor; SA, splice acceptor.
(B) Inhibition of MusD, IAP, and LINE-1 retrotransposition by APOBEC3 proteins. HeLa cells were transfected with MusD, IAP, or LINE-1 plasmids
and the indicated APOBEC3 expression vector (1:1 mass ratio for MusD and IAP and 2:1 ratio for LINE-1) and selected in G418-containing
medium. The data in (B)–(D) are normalized to the empty vector control (an average of 1002 for MusD, 268 for IAP, and 227 for LINE-1 per
10 cm dish), which was set to 100%. The data are averaged from at least three independent experiments. An immunoblot to detect expression
of the HA-tagged APOBEC3 protein in the transfected cells is shown below each bar graph (B–D).
(C) Titration of hA3A against MusD and IAP. Cells were transfected with a fixed amount of MusD or IAP (0.75 mg) and the indicated mass of hA3A
expression vector. The total mass of plasmid was held constant by addition of empty vector.
(D) Inhibition of retrotransposition by hA3A is dependent on the active site. H70R, E72Q, and C106S were cotransfected with MusD, IAP, or
LINE-1. Experiments were performed in triplicate and data are presented as the mean, with error bars reflecting the standard deviation.(Figure 2C). Numerous replication centers were seen in
cells that expressed hA3G, but these were strikingly ab-
sent in cells that expressed hA3A. Analysis of APOBEC3
localization by immunofluorescence cells showed that
hA3A was in the cytoplasm and nucleus, unlike hA3G,
hA3F, and mA3, which were confined to the cytoplasm
(Figure S3). hA3A C106S retained nuclear localization
but had no effect on the number of viral replication cen-
ters (Figure 2C). Replication and production of rAAV in
stable cell lines expressing hA3A was dramatically re-
duced, while the C106S mutant was similar to control
(Figure 2D). These results suggested that the active
site defect rather than an inability to localize to the nu-
cleus accounted for the failure of the hA3A mutant to
inhibit.
hA3A Inhibits LTR and Non-LTR Retroelements
APOBEC3 family members were tested for their ability
to inhibit retrotransposition of IAP, MusD, and LINE-1
retroelements. Retrotransposition was measured bymeans of a culture system in which cells are transfected
with a retroelement that contains a reverse orientation
neor gene that is interrupted by an intron (Figure 3A)
[21, 25]. Retrotransposition results in the integration of
a spliced DNA copy of the element. Neor colonies are
counted after selection in G418. Several APOBEC3 fam-
ily members were found to inhibit retrotransposition, in-
cluding hA3A, hA3B, hA3C, hA3F, agmA3G, macA3G,
cpzA3G, and mA3 (Figure 3B). hA3A was the most ac-
tive, inhibiting retrotransposition of the LTR (MusD and
IAP) and non-LTR (LINE-1) elements. In contrast,
hA3G, agmA3G, macA3G, and cpzA3G were nearly inac-
tive against IAP. hA3G did not inhibit LINE-1, consistent
with an earlier report [17], but hA3B, hA3C, and hA3F
were partially effective. hAPO2, included as a control,
had no effect. hA3A was expressed at a level compara-
ble to the other APOBEC proteins (Figure 3B, below),
and thus the results were not caused by overexpression.
hA3A was potent, causing 50% inhibition of MusD at
0.01 mg and IAP at 0.002 mg (Figure 3C). The potency
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contrast to its lack of activity against SIV, which is a par-
ticularly sensitive target of most APOBEC3 family mem-
bers (Figure 1A and [21]).
The hA3A active site mutants were inactive against
MusD and LINE-1 and had weak activity against IAP
(Figure 3D). Whether the weak activity against IAP is
caused by residual deaminase activity of the active
site mutants or by weak deaminase-independent inhibi-
tion [26] cannot be determined from these results. Ex-
tensive sequence analysis of transposed IAP and
MusD retroelements, surprisingly, failed to show hA3A
induced G/A mutations (Figure S4).
Expression of hA3A mRNA in Human Cells
Real-time PCR analysis showed undetectable expres-
sion of hA3A in 293 cells and mitogen-activated primary
CD4 and CD8 T cells, but significant quantities in mono-
cytes and monocyte-derived macrophages (Figure 4).
These results suggest that hA3A is expressed in cells
in addition to keratinocytes [27] and that it could have
wider expression in yet other cell types not included in
this analysis.
Conclusions
The inhibition of AAV by hA3A is the first example of an
APOBEC protein that targets a virus that replicates ex-
clusively in the nucleus and without passing through
an RNA intermediate. The ability of hA3A to enter the nu-
cleus combined with its specificity for single-stranded
DNA may contribute to its potency and to its broad
range of targets. The activity of hA3A against LINE-1 is
the first example of an APOBEC3 protein that acts on a
non-LTR retroelement. Although hA3A is active against
AAV and the retroelements, it is remarkable that it is
inactive against lentiviruses.
The absence of hA3A-induced mutations is surprising
and not yet understood. It may be that deamination
causes rapid degradation of the target DNA, preventing
PCR amplification of the mutated molecules. Alterna-
tively, inhibition could be mediated by a deaminase-
independent mechanism in which hA3A binds to single-
stranded viral DNA, interfering with the completion of
Figure 4. hA3A Is Expressed in Monocytes and Macrophages
Relative mRNA levels of hA3A in activated PBMCs, CD4+, and CD8+
T cells, monocytes, macrophages, NCCIT, and 293 cells were quan-
titated by real-time PCR and normalized according to 18S rRNA
content. The data for primary cells are representative of separate ex-
periments with cells obtained from three healthy donors. The data
are presented as the average of triplicates6 the standard deviation.DNA synthesis. The requirement for a functional active
site suggests a role for deamination; however, the single
active site of hA3A could mediate both nucleic acid
binding and catalysis [28].
It is unlikely that hA3A evolved to inhibit AAV, which is
not known to be pathogenic in humans, but hA3A could
serve to inhibit related pathogenic parvoviruses such as
B19 [18]. Potential roles for hA3A in vivo will be depen-
dent upon further analysis of its cell-type expression. It
will be of interest to understand the features of the
APOBEC3 family members that cause their different viral
specificities, how the enzymes specifically target viral
and retroviral-like sequences, and how the genome of
the cell is protected from their activity.
Supplemental Data
Supplemental Data include four figures and Supplemental Experi-
mental Procedures and can be found with this article online at
http://www.current-biology.com/cgi/content/full/16/5/480/DC1/.
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Note Added in Proof
Similar findings on the inhibition of IAP by hA3A were recently re-
ported (Bogerd, H.P., Wiegand, H.L., Doehle, B.P., Lueders, K.K.,
and Cullen, B.R. (2006). APOBEC3A and APOBEC3B are potent in-
hibitors of LTR-retrotransposon function in human cells. Nucleic
Acids Res. 34, 89–95).
